192 related articles for article (PubMed ID: 29666837)
1. Cancer telomeres and white crows.
Meeker AK
Am J Clin Exp Urol; 2018; 6(2):93-100. PubMed ID: 29666837
[TBL] [Abstract][Full Text] [Related]
2. Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology.
Meeker AK
Urol Oncol; 2006; 24(2):122-30. PubMed ID: 16520276
[TBL] [Abstract][Full Text] [Related]
3. Widespread telomere instability in prostatic lesions.
Tu L; Huda N; Grimes BR; Slee RB; Bates AM; Cheng L; Gilley D
Mol Carcinog; 2016 May; 55(5):842-52. PubMed ID: 25917938
[TBL] [Abstract][Full Text] [Related]
4. Telomeres and telomerase in prostate cancer development and therapy.
Graham MK; Meeker A
Nat Rev Urol; 2017 Oct; 14(10):607-619. PubMed ID: 28675175
[TBL] [Abstract][Full Text] [Related]
5. Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis.
Meeker AK; Hicks JL; Iacobuzio-Donahue CA; Montgomery EA; Westra WH; Chan TY; Ronnett BM; De Marzo AM
Clin Cancer Res; 2004 May; 10(10):3317-26. PubMed ID: 15161685
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN).
Koeneman KS; Pan CX; Jin JK; Pyle JM; Flanigan RC; Shankey TV; Diaz MO
J Urol; 1998 Oct; 160(4):1533-9. PubMed ID: 9751408
[TBL] [Abstract][Full Text] [Related]
7. Telomerase as a tumor marker in diagnosis of prostatic intraepithelial neoplasia and prostate cancer.
Glybochko PV; Zezerov EG; Glukhov AI; Alyaev YG; Severin SE; Polyakovsky KA; Varshavsky VA; Severin ES; Vinarov AZ
Prostate; 2014 Jul; 74(10):1043-51. PubMed ID: 24854433
[TBL] [Abstract][Full Text] [Related]
8. Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue.
Paradis V; Dargère D; Laurendeau I; Benoît G; Vidaud M; Jardin A; Bedossa P
J Pathol; 1999 Oct; 189(2):213-8. PubMed ID: 10547577
[TBL] [Abstract][Full Text] [Related]
9. MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer.
Baena-Del Valle JA; Zheng Q; Esopi DM; Rubenstein M; Hubbard GK; Moncaliano MC; Hruszkewycz A; Vaghasia A; Yegnasubramanian S; Wheelan SJ; Meeker AK; Heaphy CM; Graham MK; De Marzo AM
J Pathol; 2018 Jan; 244(1):11-24. PubMed ID: 28888037
[TBL] [Abstract][Full Text] [Related]
10. Expression-patterns of the RNA component (hTR)and the catalytic subunit (hTERT) of human telomerase in nonneoplastic prostate tissue, prostatic intraepithelial neoplasia, and prostate cancer.
Bettendorf O; Heine B; Kneif S; Eltze E; Semjonow A; Herbst H; Stein H; Böcker W; Poremba C
Prostate; 2003 May; 55(2):99-104. PubMed ID: 12661034
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in telomere biology: implications for human cancer.
Meeker AK; De Marzo AM
Curr Opin Oncol; 2004 Jan; 16(1):32-8. PubMed ID: 14685090
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium.
Zhang W; Kapusta LR; Slingerland JM; Klotz LH
Cancer Res; 1998 Feb; 58(4):619-21. PubMed ID: 9485010
[TBL] [Abstract][Full Text] [Related]
13. [Prostate-specific antigen and telomerase in prostatic cancers].
Poliakovskiĭ KA; Glukhov AI; zezerov EG; Varshavskiĭ VA; Vinarov AZ; Amosov AV; Rapoport LM; Aliaev IuG; Severin ES; Zimnik OV
Klin Lab Diagn; 2008 Dec; (12):37-8. PubMed ID: 19198276
[TBL] [Abstract][Full Text] [Related]
14. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
Gancarcíková M; Zemanová Z; Brezinová J; Berková A; Vcelíková S; Smigová J; Michalová K
Prague Med Rep; 2010; 111(2):91-105. PubMed ID: 20653999
[TBL] [Abstract][Full Text] [Related]
15. Resolving the Coffey Paradox: what does the androgen receptor do in normal vs. malignant prostate epithelial cells?
Isaacs JT
Am J Clin Exp Urol; 2018; 6(2):55-61. PubMed ID: 29666833
[TBL] [Abstract][Full Text] [Related]
16. The roles of telomeres and telomerase in cellular immortalization and the development of cancer.
Klingelhutz AJ
Anticancer Res; 1999; 19(6A):4823-30. PubMed ID: 10697595
[TBL] [Abstract][Full Text] [Related]
17. Stem cell features of benign and malignant prostate epithelial cells.
De Marzo AM; Nelson WG; Meeker AK; Coffey DS
J Urol; 1998 Dec; 160(6 Pt 2):2381-92. PubMed ID: 9817389
[TBL] [Abstract][Full Text] [Related]
18. Implications of telomeres and telomerase in endometrial pathology.
Hapangama DK; Kamal A; Saretzki G
Hum Reprod Update; 2017 Mar; 23(2):166-187. PubMed ID: 27979878
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity modulation in the prevention of prostate cancer.
Kim NW; Hruszkewycz AM
Urology; 2001 Apr; 57(4 Suppl 1):148-53. PubMed ID: 11295615
[TBL] [Abstract][Full Text] [Related]
20. Telomere and telomerase in stem cells.
Hiyama E; Hiyama K
Br J Cancer; 2007 Apr; 96(7):1020-4. PubMed ID: 17353922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
